INTERVIEW: Pre Diagnostics takes new approach to Alzheimer's blood test
This article was originally published in Clinica
Executive Summary
Many companies and researchers are trying to develop a blood test for Alzheimer’s disease – but Norway’s Pre Diagnostics is taking a different approach that it believes will give it the edge over its rivals. Clinica spoke to chief scientific officer Frank Swenson